Luis O Leal Selected Research

Breakthrough Infections

1/2021

Invasive fungal disease and the immunocompromised host including allogeneic hematopoietic cell transplant recipients: Improved understanding and new strategic approach with sargramostim.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luis O Leal Research Topics

Disease

3	Mycoses (Diseases, Fungus) 11/2022 - 01/2020
3	Infections 01/2021 - 01/2020
2	Neoplasms (Cancer) 11/2022 - 01/2020
2	Neutropenia 11/2022 - 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 11/2022
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Breakthrough Infections 01/2021
1	COVID-19 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021

Drug/Important Bio-Agent (IBA)

4	sargramostim (Leukine)FDA Link 11/2022 - 01/2020
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2021 - 01/2020
1	Immunologic Factors (Immunomodulators)IBA 11/2022
1	posaconazole FDA Link 01/2021
1	Itraconazole (Sporanox)FDA LinkGeneric 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Micafungin (FK463)FDA Link 01/2021
1	Voriconazole (Vfend)FDA LinkGeneric 01/2021
1	Caspofungin (Cancidas)FDA Link 01/2021
1	Tec protein-tyrosine kinaseIBA 01/2020
1	ibrutinibIBA 01/2020

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 11/2022 - 01/2021
2	Therapeutics 11/2022 - 01/2021
1	Immunotherapy 11/2022